See also this year's filing and all EDGAR filings for this company.
PDF Report 0001607678_2017_Viking_Therapeutics_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001607678')"} |
Graph
Absolute values for 0001607678, Viking Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 13,974,829 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 560,879 |
4 | LiabilitiesCurrent | 6,476,534 |
5 | LiabilitiesNoncurrent | 16,307 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 4,846,776 |
9 | ResearchAndDevelopmentExpense | 9,000,499 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | -884,547 |
13 | remainder_ComprehensiveNetIncome | 478 |
yvar | yval | |
---|---|---|
0 | Assets | 14,535,708 |
1 | Liabilities | 6,492,841 |
2 | Expenses | 13,847,275 |
3 | Revenues | 0 |
4 | StockholdersEquity | 8,042,867 |
5 | NetIncome | -14,731,822 |
6 | ComprehensiveNetIncome | -14,731,583 |
7 | BaseVar | 17,880,424 |
8 | EconomicCapitalRatio | -0.0854 |